FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Magellan Diagnostics Recalls Blood Lead Tests

[ Price : $8.95]

Magellan Diagnostics recalls its LeadCare II, LeadCare Plus, and LeadCare Ultra blood lead tests due to concerns about false low r...

FDA Staff Update on Data Integrity Issues

[ Price : $8.95]

A panel of FDA staff from CDER and the Office of Regulatory Affairs provide the latest insights into common data integrity inspect...

CBERs Marks Takes Over Vaccine Review Office

[ Price : $8.95]

CBER director Peter Marks announces he will immediately serve as Office of Vaccines Research and Review (OVRR) acting director, re...

Guide on Nontuberculous Mycobacterial Pulmonary Disease

[ Price : $8.95]

Federal Register notice: FDA makes available a draft guidance on developing drugs for treating Nontuberculous Mycobacterial Pulmon...

Draft 510(k) eSubmission Template

[ Price : $8.95]

Federal Register notice: FDA makes available a draft guidance entitled Electronic Submission Template for Medical Device 510(k) Su...

Pfizer to Seek Covid Vaccine EUA for Children 5-12

[ Price : $8.95]

Pfizer and BioNTech say they will seek in the coming weeks an emergency use authorization from FDA for their Covid-19 vaccine in c...

Guidance on Using Electronic Records, Claims Data in RWD

[ Price : $8.95]

FDA issues a draft guidance on the use of two sources of real-world data to support regulatory decision-making.

Condemned Labz Selling Illegal New Drugs: FDA

[ Price : $8.95]

FDA warns Condemned Labz that it is marketing misbranded unapproved new drugs.

PhRMA Comments on FDA Safety Reporting Guide

[ Price : $8.95]

PhRMA tells FDA it appreciates many of the revisions the agency has made to a draft guidance on sponsor responsibilities for safet...

Priority Review for ViiVs Cabotegravir HIV Preventer

[ Price : $8.95]

FDA grants priority review to ViiVs cabotegravir to prevent acquisition of HIV in certain men.